Dr Dumanski is a Clinical Assistant Professor in the Department of Medicine at the University of Calgary. She received a Medical Degree from the University of Saskatchewan, followed by clinical residencies in Internal Medicine and Nephrology, a Master of Medical Science from the University of Calgary, and a Master’s Certificate in Health Systems Management from the Johnson-Shoyama School of Public Policy. 

Dr Dumanski’s program of research merges her clinical expertise in kidney and cardiovascular disease with her scientific background in vascular physiology, and endeavors to understand the impact of sex and gender on cardiorenal outcomes in women and men. Specifically, Dr Dumanski investigates the implications of fertility and the effect of fertility-related hormones on micro- and macro- vascular health. She has a special interest in anti-Mullerian hormone, a sex hormone secreted by both females and males to augment fertility, and its physiologic role in both kidney and cardiovascular outcomes. Ongoing studies seek to further understand the complex relationships between fertility, endogenous and exogenous sex hormones, parity, vascular dysfunction, and cardiovascular risk in women and men with and without kidney disease. 

Dr Dumanski presently sits on the Canadian Women’s Heart Health Alliance Advocacy Committee, as well as the Hypertension Canada guidelines Central Review Committee. She is passionate about knowledge translation and community engagement, and volunteers her time with local community interest groups.